In cancer research, PRMT7 is of significant interest due to its varying expression across several cancers, including prostate cancer, breast cancer, melanoma, non-small-cell lung cancer (NSCLC), gastric cancer, T-ALL, liver cancer, and renal cell carcinoma. Here, PRMT7 is linked to breast carcinoma.